Yatırımcı.AI

BISTTRY18:19Live

Tab Gıda Sanayi ve Ticaret A.Ş.

TABGD Price Target 2026Tab Gıda Sanayi ve Ticaret A.Ş.

Star MarketFood, Beverage and Tobacco
221.900.20 (0.09%)
Volume
TRY 84.2M
Day range
217.00 – 223.20
Previous close
221.70
Market cap
TRY 58B

Last updated: Source: Borsa Istanbul, 15-minute delayed

The average price target of 12 brokers for TABGD is TRY 368.25 (September 18, 2026), implying 65.95% from the last price.

Broker price targets, buy-hold-sell ratings and model portfolio status for Tab Gıda Sanayi ve Ticaret A.Ş. (TABGD). The average target is compared with the current price to derive the implied upside; the AI fair value estimate is shown for comparison.

Last updated: Source: Broker research

Analyst Consensus

Average target
368.25 TL
Median target
362.15 TL
Highest target
411.41 TL
Lowest target
323.00 TL
Upside
65.95%
Buy / Hold / Sell
10 / 0 / 0

Broker Price Targets

GedikGedikSeptember 18, 2026Outperform405.6082.79%
Ak YatirimAk YatirimAugust 26, 2026Outperform361.0062.69%
TacirlerTacirlerAugust 6, 2026Buy411.0085.22%
DenizDenizAugust 6, 2026Buy375.0069.00%
Yapı KrediYapı KrediAugust 6, 2026Buy375.0069.00%
OyakOyakAugust 4, 2026Outperform349.0057.28%
HSBCHSBCJuly 10, 2026Buy360.0062.24%
İş Yatırımİş YatırımJune 15, 2026Buy411.4185.40%
IntegralIntegralJanuary 22, 2026ÖNERİ YOK359.7162.10%
CitiCitiJanuary 22, 2026Buy325.0046.46%
TeraTeraJanuary 21, 2026Outperform363.3063.72%
A1 CapitalA1 CapitalJanuary 13, 2026ÖNERİ YOK323.0045.56%

AI Fair Value

AI fair value
222.12 TL
Upside
0.10%
Model date
July 21, 2026
Analyst price targets for all stocks

Frequently Asked Questions

12 brokers have an average target of TRY 368.25 for TABGD, with 10 buy, 0 hold and 0 sell ratings.

The highest price target for TABGD is TRY 411.41, the lowest is TRY 323.00 and the median is TRY 362.15.

Our AI fair value model estimates TRY 222.12 for TABGD, a difference of 0.10% from the current price. The model was updated on July 21, 2026. Not investment advice.

No. Price targets are opinions from broker research reports, provided for information only, not a recommendation to buy or sell.